LYMPHOMA

Browse all LYMPHOMA
Bispecifics, BTK Inhibitors, and Immunotherapy Drive Lymphoma Advances

LYMPHOMA

Bispecifics, BTK Inhibitors, and Immunotherapy Drive Lymphoma Advances

Julie Vose, MD, MBA, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Insights on CAR-NK Therapy and Hodgkin Lymphoma Updates at ASH 2025

LYMPHOMA

Insights on CAR-NK Therapy and Hodgkin Lymphoma Updates at ASH 2025

Sam Yamshon, MD, Andrew Evens, DO, MBA, MSc

Oncologists Review Practice-Changing Lymphoma Findings From ASH 2025

LYMPHOMA

Oncologists Review Practice-Changing Lymphoma Findings From ASH 2025

Kingsley Nnawuba, MD, Urshila Durani, MD, MPH

Experts Discuss Sonrotoclax and Lymphoma Trials at ASH 2025

LYMPHOMA

Experts Discuss Sonrotoclax and Lymphoma Trials at ASH 2025

Agrima Mian, MD, Sam Yamshon, MD

LEUKEMIA

Browse all LEUKEMIA
AML and CML Highlights From ASH 2025

LEUKEMIA

AML and CML Highlights From ASH 2025

Jorge Cortes, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Azacitidine in AML: Key Takeaways From the PARADIGM Study

LEUKEMIA

Azacitidine in AML: Key Takeaways From the PARADIGM Study

Jayastu Senapati, MBBS, Uma Borate, MBBS

Targeted Combinations Transform AML Care

LEUKEMIA

Targeted Combinations Transform AML Care

Abhishek Maiti, MD, Jorge Cortes, MD

ASH 2025 CML Highlights: Asciminib, Ponatinib Optimization, and Treatment Sequencing

LEUKEMIA

ASH 2025 CML Highlights: Asciminib, Ponatinib Optimization, and Treatment Sequencing

Sawyer Bawek, DO, Fadi Haddad, MD

MULTIPLE MYELOMA

Browse all MULTIPLE MYELOMA
AQUILA, COBRA, TecLILLE, and MajesTEC-3 Trials Signal Shifts in Myeloma Management

MULTIPLE MYELOMA

AQUILA, COBRA, TecLILLE, and MajesTEC-3 Trials Signal Shifts in Myeloma Management

Ben Derman, MD, Rahul Gosain, MD, MBA, Rohit Gosain, MD

Collaboration is Key to Safely Transition Care in MM Following Cellular Therapy

MULTIPLE MYELOMA

Collaboration is Key to Safely Transition Care in MM Following Cellular Therapy

Hamza Hashmi, MD, Shreyas Kalantri, MD

Early Intervention Strategies in High-Risk Smoldering Multiple Myeloma

MULTIPLE MYELOMA

Early Intervention Strategies in High-Risk Smoldering Multiple Myeloma

Anuja V. Abhyankar, MD, Jing Wang, MD

How to Select Treatment in Relapsed Multiple Myeloma

MULTIPLE MYELOMA

How to Select Treatment in Relapsed Multiple Myeloma

Anuja V. Abhyankar, MD, S. Vincent Rajkumar, MD